GlobeNewswire
-
TOMI Environmental Solutions Regains Compliance with Nasdaq Minimum Bid Price and Stockholders’ Equity Requirements
17/11/2026 -
Conexeu Sciences Announces Early-Stage Development of W.A.F.E.R.™ Sheet and W.A.F.E.R.™ Lattice, Fabricated Formats of Its Investigational CXU™ Platform
17/11/2026 -
GATC Health and Hesperos Partner to Build FDA-Aligned NAMs Workflow That Aims to Cut Time and Cost of Preclinical Testing
17/11/2026 -
Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications
17/11/2026 -
Vittoria Biotherapeutics to Present Phase 1 Results for Senza5 CART5 in T-Cell Lymphoma in an Oral Session and LampTAC Degrader Platform Data in a Poster Session at ASH 2026
17/11/2026 -
CytoDyn Appoints Lauren Wilcoxen, Ph.D., as Chief Operating Officer and Head of Regulatory Affairs
17/11/2026 -
Veru Presents New Results at ObesityWeek 2026: GLP-1 Weight Loss in Older Adults Associated with Physical Function Decline; Adding Enobosarm Preserved Significant Lean Mass and Physical Function
17/11/2026 -
Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
MAIA Biotechnology Reports Consistent Strong Efficacy in Expanded Phase 2 THIO-101 Study in Non-Small Cell Lung Cancer
17/11/2026 -
Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
Persevere Therapeutics Appoints Alex Martin and Meenu Chhabra Karson to its Board of Directors
17/11/2026 -
NEXGEL to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 19th
17/11/2026 -
AdvantageCare Physicians (ACPNY) Earns Patient-Centered Medical Home (PCMH) Recognition for Eighth Consecutive Year
17/11/2026 -
PerfectServe Uses Twilio to Power Natural Voice Conversations in Intelligent Answering
17/11/2026 -
Myriad Genetics Expands SRL Partnership in Japan to Support Future Growth
17/11/2026 -
Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors
17/11/2026 -
Pharmascience Canada lance un nouveau produit
17/11/2026 -
Pharmascience Canada launches a new product
17/11/2026 -
OneMedNet Reports Third Quarter 2026 Financial Results and Reiterates Fourth Quarter 2026 Outlook
17/11/2026
Pages